We demonstrate that Aα-Val360 is a marker of cross-sectional COPD disease severity and possibly disease progression, and represents a new concept of specific ...
Conclusions: Aα-Val(360) represents the first specific footprint of pre-inhibition NE activity and is a potential biomarker of disease activity and progression ...
Aα-Val360 is a neutrophil elastase specific biomarker that relates to COPD disease activity and treatment and may fulfil the essential criteria of a biomarker.
Apr 20, 2012 · We demonstrate that Aα-Val(360) is a marker of cross-sectional COPD disease severity and possibly disease progression, and represents a new ...
Value Protection ; Service Retention ; Trade Credit. Sales Retention ; Training ; Technology Driven.
₹1,400.00
Val 360 is a synergistic blend containing combined extracts of Sphaeranthus indicus flower heads and Garcinia mangostana fruit. VAL 360® supports normalizing ...
60 Aa-Val 360 is a NE-specific fibrinogen degradation product reflecting lung elastolytic activity. Plasma levels are raised in stable COPD (especially in AATD) ...
In cross-sectional studies, Aa-Val360 reflects disease severity in AATD and may be a useful marker of disease activity in patients with early disease in whom ...
Jan 12, 2024 · We demonstrate that Aα-Val(360 )is a marker of cross-sectional COPD disease severity and possibly disease progression, and represents a new ...
Aα-Val360 (a specific footprint of neutrophil elastase activity in vivo) showed a positive correlation with the degree of emphysema as assessed by the % low ...